Somatostatin analogues in the management of benign insulinomas
Laron, Z.
Israel Journal of Medical Sciences 26(1): 1-2
1990
ISSN/ISBN: 0021-2180 PMID: 2155883 Document Number: 365453
Document emailed within 1 workday
Related Documents
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741Lorcy, Y.; Le Moullec, N.; Le Guerrier, A.M.; Allannic, H. 1992: Somatostatin analogues in the treatment of paraneoplastic hypercorticism Presse Medicale 21(39): 1873
Anthony, L.B. 1999: Long-acting formulations of somatostatin analogues Italian Journal of Gastroenterology and Hepatology 31(Suppl): S216-S218
García Lafuente, N.; Berná Gascón, M.T.; Pujalte López, E.; Falcó Jover, G.; Domínguez Escribano, J.R. 2001: Response of thyrotropinoma to somatostatin analogues: report of a case Anales de Medicina Interna 18(12): 663
De Jong, M.; Breeman, W.A.; Bernard, H.F.; Kooij, P.P.; Slooter, G.D.; Van Eijck, C.H.; Kwekkeboom, D.J.; Valkema, R.; Mäcke, H.R.; Krenning, E.P. 1999: Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 43(4): 356-366
Breeman, W.A.; Bakker, W.H.; De Jong, M.; Hofland, L.J.; Kwekkeboom, D.J.; Kooij, P.P.; Visser, T.J.; Krenning, E.P. 1996: Studies on radiolabeled somatostatin analogues in rats and in patients Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 40(3): 209-220
Vialettes, B.; Mallet, B. 1992: Somatostatin analogues: a therapeutic tool in proliferative diabetic retinopathy? Journees Annuelles de Diabetologie de l'Hotel-Dieu 1992: 63-70
Batzri, S.; Harmon, J.W. 1988: Effects of somatostatin and its analogues on dispersed gastric mucosal cells Surgery 104(5): 934
Bodei, L.; Pepe, G.; Paganelli, G. 2010: Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues European Review for Medical and Pharmacological Sciences 14(4): 347-351
Setyono-Han, B.; Henkelman, M.S.; Foekens, J.A.; Klijn, G.M. 1987: Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells Cancer Research 47(6): 1566-1570
Gut, P.ł; Ruchała, M. 2019: Evaluation of 5-hydroxyindoloacetic acid excretion in urine in patients with small intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues Neuro Endocrinology Letters 40(7-8): 315-318
Matsuo, H.; Maruo, T. 2006: GnRH analogues in the management of uterine leiomyoma Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 4): 75-79
Avgerinos, A.; Armonis, A.; Raptis, S. 1995: Somatostatin and octreotide in the management of acute variceal hemorrhage Hepato-Gastroenterology 42(2): 145-150
Bastounis, E.; Hadjinikolaou, L.; Ioannou, N.; Papastamatiou, M.; Toumbis, E.; Makri, G. 1989: Somatostatin as adjuvant therapy in the management of obstructive ileus Hepato-Gastroenterology 36(6): 538-539
Ferone, D.; Arvigo, M.; Semino, C.; Pivonello, R.; van Hagen, P.M.; Barreca, A.; Minuto, F. 2003: The role of somatostatin analogs in the management of immunoproliferative disease Journal of Endocrinological Investigation 26(8 Suppl): 103-108
D'Agostino, L.; Manguso, F.; Pivonello, R.; Colao, A. 2003: The role of somatostatin analogs in the management of hepatocellular carcinoma Journal of Endocrinological Investigation 26(8 Suppl): 131-133
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C. 1993: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28 Molecular Pharmacology 44(6): 1278
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K. 1991: Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation Transplantation Proceedings 23(1 Part 1): 348
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229